Le Lézard
Classified in: Science and technology
Subjects: Conference, Webcast

Innovid to Participate in Upcoming Investor Conferences


Innovid Corp. (NYSE:CTV) (the "Company"), a leading software platform for the creation, delivery, measurement, and optimization of advertising across connected TV (CTV), linear TV, and digital, today announced that management will participate in the following investor conferences:

Oppenheimer 9th Annual Emerging Growth Conference
When: Thursday, May 9, 2024
Where: Virtual

19th Annual Needham Technology, Media, & Consumer Conference
When: Tuesday, May 14, 2024
Fireside Chat: 2:15 p.m. ET
Where: New York, N.Y.

Oppenheimer 25th Annual Israeli Conference
When: Sunday, May 26, 2024
Where: Tel Aviv, Israel

There will be a live video webcast for the Needham Technology, Media, & Consumer Conference, and a replay will be available for 90 days at investors.innovid.com. For more information regarding the conferences, visit Innovid's events page here.

About Innovid

Innovid (NYSE:CTV) is a leading enterprise software platform for the creation, delivery, measurement, and optimization of advertising across connected TV (CTV), linear TV, and digital. Through a global infrastructure that enables cross-platform ad serving, data-driven creative, and measurement, Innovid offers its clients always-on intelligence to optimize advertising investments across channels, platforms, screens, and devices. Innovid is an independent platform that leads the market in converged TV innovation, through proprietary technology and exclusive partnerships designed to reimagine TV advertising. Headquartered in New York City, Innovid serves a global client base through offices across the Americas, Europe, and Asia Pacific. To learn more, visit innovid.com or follow us on LinkedIn or X.


These press releases may also interest you

at 06:02
Weekly Recap: 11 Press Releases You Might Have Missed
With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help journalists and consumers stay on top of the week's most newsworthy and popular releases, here's a recap of some major...

at 06:00
Amplify10 Unveils Groundbreaking AI-Powered Sales Execution Platform, Revolutionizing Enterprise Sales Performance
Amplify10, the trailblazer in SaaS AI-Powered Sales Execution solutions, proudly announces its official launch today, aimed at reshaping the landscape of sales performance for enterprises worldwide. The early-stage company, formerly known as...

at 06:00
Quhuo Announces Changes to Board of Directors
Quhuo Limited ("Quhuo" or the "Company") , a leading gig economy platform focusing on local life services in China, today announced that Ms. Chenxi Zhao has resigned from her position as a member of the board of directors (the "Board"), effective on...

at 05:50
NADclinic and Bontac Bio-Engineering (Shenzhen) Co., Ltd Announce Strategic Partnership to Evolve the Future of Global Wellness Through the Power of NAD+
NADclinic Group and Bontac Bio-Engineering (Shenzhen) Co., Ltd have officially entered into a dynamic strategic partnership to collaboratively focus on the future of global health and wellness. Synergistically leveraging their collective expertise...

at 05:45
China Duty Free Group outlines growth strategy at TFWA Asia Pacific Conference
A report from China.org.cn:  China Duty Free Group (CDFG), the world's leading travel retail operator, outlined its strategy for continued growth at the recently concluded TFWA Asia Pacific Exhibition & Conference held in Singapore from May 12 to...

at 05:35
Drug Farm Announces IND Clearance by U.S. FDA Enabling Phase 1b Initiation for ALPK1 Selective Kinase Inhibitor, DF-003 in ROSAH Syndrome Patients
Drug Farm announced today the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application of DF-003, a first-in-class, oral, potent, highly selective alpha-kinase 1 (ALPK1) inhibitor for clinical evaluation in...

More news about Science and technology...


News published on and distributed by: